2024 White clot quantitative results

TL;DR

Survey shows increased reports of white fibrous clots in corpses.

Transcript

so here on question two uh yeah we we basically asked again this year in 2024 have you seen the white fibrous clots and look at that John 250 out of the 301 inv bolers responding to this survey this year said they are indeed still seeing the these White Fiber squads so it's been up so it's actually gone up so this was what what time... Read More

Key Insights

• Survey results indicate that 83% of embalmers have observed white fibrous clots in corpses in 2024, a notable increase from previous years.
• The phenomenon of white fibrous clots is considered new, emerging post-2020, and has not yet been widely documented in pathology journals.
• There is a notable discrepancy between embalmers' observations and the lack of reports from pathologists, leading to confusion and concern within the community.
• The stigma around reporting these findings seems to be decreasing, allowing more embalmers to admit observing the clots.
• There is a call for more official investigations and publications to validate and understand the cause and implications of these clots.
• Microclotting, described as 'coffee grounds' or 'dirty blood,' has also been reported in 22% of cases, slightly down from the previous year's 25%.
• The embalmers' professional associations have largely not addressed the issue, with less than 20% discussing it in any formal capacity.
• There is a need for more data collection and open discussion among embalmers to better understand the prevalence and implications of these clots.

Questions & Answers

Q: What are the main findings of the 2024 embalmer survey regarding white fibrous clots?

The survey indicates that 83% of embalmers have observed white fibrous clots in corpses in 2024, marking an increase from previous years. This phenomenon is considered new, emerging post-2020, and has yet to be widely documented in pathology journals. The survey results suggest a growing acknowledgment among embalmers of these clots' existence.

Q: Why is there a discrepancy between embalmers' observations and pathology reports?

The discrepancy may be due to the different processes involved in embalming and pathology. Embalmers flush out the circulatory system, potentially observing clots that pathologists, focusing on main organ groups, might miss. Additionally, the lack of published reports in pathology journals could be due to the controversial nature of the findings, making publication difficult.

Q: How has the stigma around reporting white fibrous clots changed?

The stigma appears to be decreasing, as more embalmers are willing to admit observing these clots. This change is attributed to the phenomenon's increased recognition and the embalmers' awareness from previous surveys that others are also reporting similar findings. The reduced stigma may lead to more open discussions and data sharing.

Q: What is microclotting, and how prevalent is it in 2024?

Microclotting, described by embalmers as 'coffee grounds' or 'dirty blood,' refers to small blood clots observed during the embalming process. In 2024, 22% of embalmers reported seeing microclotting in corpses, a slight decrease from 25% the previous year. Microclotting is considered dangerous as it can block capillaries and impede oxygen exchange.

Q: Why have professional associations not addressed the issue of white fibrous clots?

Less than 20% of embalmers reported that their professional associations have discussed the issue. This lack of discussion could be due to the controversial nature of the findings, potential stigma, or a reluctance to address unverified phenomena. The absence of formal acknowledgment highlights the need for more data collection and open discussion.

Q: What are the implications of embalmers' findings on public health?

The findings raise concerns about the potential prevalence of white fibrous clots and microclotting in the general population. If these phenomena are occurring pre-death, they could indicate underlying health issues that contribute to strokes, heart attacks, or other conditions. The need for further investigation and validation of these findings is critical for public health.

Q: How have embalmers' attitudes towards reporting these findings changed?

Embalmers' attitudes have shifted towards greater openness in reporting these findings. Some embalmers feel an ethical obligation to report the clots as a potential threat to public health. However, others remain skeptical, viewing reports and discussions as propaganda. This divide indicates a need for clearer communication and validation of data.

Q: What steps are suggested to improve understanding of the white fibrous clots phenomenon?

To improve understanding, there is a call for more data collection, open discussion among embalmers, and official investigations. Publishing findings in medical journals would help validate the phenomenon and facilitate further research. Encouraging embalmers to track and report their observations systematically could provide valuable insights into the clots' prevalence and implications.

Summary & Key Takeaways

• The 2024 survey of embalmers reveals a significant increase in the observation of white fibrous clots in corpses, a phenomenon that has emerged post-2020. Despite the increase, there is a lack of documentation in pathology journals, causing concern and confusion.

• The survey suggests that the stigma around reporting these findings is decreasing, allowing more embalmers to admit to observing the clots. However, the discrepancy between embalmers' observations and the lack of reports from pathologists remains unexplained.

• Microclotting has been reported in 22% of cases, slightly lower than last year. Professional associations have largely not addressed the issue, highlighting the need for more data collection and open discussion to understand the prevalence and implications of these clots.